Table 6 KEGG pathways.

From: A network pharmacology-based approach to explore potential targets of Caesalpinia pulcherima: an updated prototype in drug discovery

Description

Count in gene set

False discovery rate

Pathways in cancer

28

1.08 × 10–15

PI3K-Akt signaling pathway

24

1.11 × 10–15

EGFR tyrosine kinase inhibitor resistance

12

3.19 × 10–11

Metabolic pathways

33

1.13 × 10–10

Ras signaling pathway

16

1.46 × 10–10

Proteoglycans in cancer

15

1.78 × 10–10

MAPK signaling pathway

17

3.66 × 10–10

Endocrine resistance

11

1.93 × 10–09

AGE-RAGE signaling pathway in diabetic complications

11

2.33 × 10–09

Rap1 signaling pathway

14

2.33 × 10–09

Back to article page